Supreme Court Upholds Mifepristone Access in Unanimous Decision

Pregnancy Information

Author: American Psychological Association (APA)
Published: 2024/06/14 - Updated: 2024/07/12
Publication Type: Announcement - Peer-Reviewed: Yes
Contents: Summary - Definition - Introduction - Main - Related

Synopsis: American Psychological Association (APA) applauds U.S. Supreme Court’s opinion allowing Mifepristone, a drug commonly used for medical abortions to remain on the market. In a unanimous opinion, the Supreme Court ruled that the anti-abortion groups that initially sued the FDA lacked standing to bring the case in the first place, leaving all previous FDA actions intact.

Introduction

Following the U.S. Supreme Court's landmark 2022 decision overturning Roe v. Wade, a group of anti-abortion activists sued the U.S. Food and Drug Administration, challenging its approval of mifepristone, a drug commonly used in medical abortions - [Also listed on the WHO List of Essential Medicines]. A federal judge initially suspended the FDA's approval of the drug, but a subsequent decision by a court of appeals reinstated approval while simultaneously striking down the FDA's previous changes in 2016 to ease access.

Main Digest

"We are pleased that the court has preserved access to this drug. Policies based on the concept that abortion is harmful to women's mental health are not supported by scientific evidence. Research has consistently shown that having an abortion is not linked to mental health problems, but people who are denied abortions have worse physical and mental health, as well as economic outcomes," said APA CEO Arthur C. Evans Jr., PhD.

In a unanimous opinion, the Supreme Court ruled that the anti-abortion groups that initially sued the FDA lacked standing to bring the case in the first place, leaving all previous FDA actions intact.

In conjunction with the National Association of Social Workers, APA submitted an amicus brief supporting the FDA in the Supreme Court case, arguing that the lower courts' decisions "incorrectly asserted that medication abortion is linked to negative physical and mental health outcomes."

The brief sought "to make this Court aware of the flawed evidence undergirding the lower courts' reasoning in these cases," providing scientific evidence that not only were voluntary abortions not associated with negative physical or mental health outcomes, but denial of access to abortion care leads to greater levels of anxiety, lower self-esteem and negative socio-economic and physical health outcomes.

APA has long been a voice for equal access to reproductive health services. The association has passed four policies or resolutions since 1969 affirming a woman's right to choose and negating assertions regarding the alleged adverse psychological effects of abortion. APA has also filed 12 amicus curiae briefs in cases involving abortion. The most recent policy was passed in February 2022.

For more information regarding APA's advocacy and the science surrounding abortion and reproductive health, visit APA's abortion and mental health webpage.

Interesting Related Information

Attribution/Source(s):

This peer reviewed publication was selected for publishing by the editors of Disabled World due to its significant relevance to the disability community. Originally authored by American Psychological Association (APA), and published on 2024/06/14 (Edit Update: 2024/07/12), the content may have been edited for style, clarity, or brevity. For further details or clarifications, American Psychological Association (APA) can be contacted at apa.org. NOTE: Disabled World does not provide any warranties or endorsements related to this article.

Related Publications

Share This Information To:
𝕏.com Facebook Reddit

Page Information, Citing and Disclaimer

Disabled World is an independent disability community founded in 2004 to provide news and information to people with disabilities, seniors, their family and carers. We'd love for you to follow and connect with us on social media!

Cite This Page (APA): American Psychological Association (APA). (2024, June 14 - Last revised: 2024, July 12). Supreme Court Upholds Mifepristone Access in Unanimous Decision. Disabled World. Retrieved July 17, 2024 from www.disabled-world.com/health/female/pregnancy/mifepristone-legal.php

Permalink: <a href="https://www.disabled-world.com/health/female/pregnancy/mifepristone-legal.php">Supreme Court Upholds Mifepristone Access in Unanimous Decision</a>: American Psychological Association (APA) applauds U.S. Supreme Court’s opinion allowing Mifepristone, a drug commonly used for medical abortions to remain on the market.

Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.